The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Multiplexed Diagnostics Market Research Report 2025
Synopsis
The key to multiplexing is miniaturization. Instead of having just one assay in a well a whole array of miniaturized, spotted assays is analyzed simultaneously. Combining several tests brings significant savings in time and money.
The global Multiplexed Diagnostics market was valued at US$ 1958.3 million in 2023 and is anticipated to reach US$ 3332.9 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.
The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify the existing applications in multiplexed diagnostics, the development in generic platforms, and a greater use of multiplexed diagnostics in academic and research organizations.
This report aims to provide a comprehensive presentation of the global market for Multiplexed Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiplexed Diagnostics.
Report Scope
The Multiplexed Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multiplexed Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multiplexed Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies
Bio-Rad Laboratories
BioMerieux
F. Hoffmann-La Roche
Illumina
Luminex
Hologic
Thermo Fisher Scientific
Siemens Healthineers
Abbott Laboratories
Segment by Type
Very High Density Multiplexed Assays (Above 10,000-plex)
High Density Multiplexed Assays (500 Below plex Below 10,000)
Medium Density Multiplexed Assays (plex Below 500)
Low Density Multiplexed Assays (plex Below 5)
Next Generation Sequencing Assays
Segment by Application
Academic Research Institutes
Hospital
Pharmaceutical Companies
Clinical Research Organizations
Diagnostic Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multiplexed Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The key to multiplexing is miniaturization. Instead of having just one assay in a well a whole array of miniaturized, spotted assays is analyzed simultaneously. Combining several tests brings significant savings in time and money.
The global Multiplexed Diagnostics market was valued at US$ 1958.3 million in 2023 and is anticipated to reach US$ 3332.9 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.
The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify the existing applications in multiplexed diagnostics, the development in generic platforms, and a greater use of multiplexed diagnostics in academic and research organizations.
This report aims to provide a comprehensive presentation of the global market for Multiplexed Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiplexed Diagnostics.
Report Scope
The Multiplexed Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multiplexed Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multiplexed Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies
Bio-Rad Laboratories
BioMerieux
F. Hoffmann-La Roche
Illumina
Luminex
Hologic
Thermo Fisher Scientific
Siemens Healthineers
Abbott Laboratories
Segment by Type
Very High Density Multiplexed Assays (Above 10,000-plex)
High Density Multiplexed Assays (500 Below plex Below 10,000)
Medium Density Multiplexed Assays (plex Below 500)
Low Density Multiplexed Assays (plex Below 5)
Next Generation Sequencing Assays
Segment by Application
Academic Research Institutes
Hospital
Pharmaceutical Companies
Clinical Research Organizations
Diagnostic Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multiplexed Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiplexed Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Very High Density Multiplexed Assays (Above 10,000-plex)
1.2.3 High Density Multiplexed Assays (500 Below plex Below 10,000)
1.2.4 Medium Density Multiplexed Assays (plex Below 500)
1.2.5 Low Density Multiplexed Assays (plex Below 5)
1.2.6 Next Generation Sequencing Assays
1.3 Market by Application
1.3.1 Global Multiplexed Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Academic Research Institutes
1.3.3 Hospital
1.3.4 Pharmaceutical Companies
1.3.5 Clinical Research Organizations
1.3.6 Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multiplexed Diagnostics Market Perspective (2019-2030)
2.2 Multiplexed Diagnostics Growth Trends by Region
2.2.1 Global Multiplexed Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Multiplexed Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Multiplexed Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Multiplexed Diagnostics Market Dynamics
2.3.1 Multiplexed Diagnostics Industry Trends
2.3.2 Multiplexed Diagnostics Market Drivers
2.3.3 Multiplexed Diagnostics Market Challenges
2.3.4 Multiplexed Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiplexed Diagnostics Players by Revenue
3.1.1 Global Top Multiplexed Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Multiplexed Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Multiplexed Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multiplexed Diagnostics Revenue
3.4 Global Multiplexed Diagnostics Market Concentration Ratio
3.4.1 Global Multiplexed Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiplexed Diagnostics Revenue in 2023
3.5 Multiplexed Diagnostics Key Players Head office and Area Served
3.6 Key Players Multiplexed Diagnostics Product Solution and Service
3.7 Date of Enter into Multiplexed Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiplexed Diagnostics Breakdown Data by Type
4.1 Global Multiplexed Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Multiplexed Diagnostics Forecasted Market Size by Type (2025-2030)
5 Multiplexed Diagnostics Breakdown Data by Application
5.1 Global Multiplexed Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Multiplexed Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Multiplexed Diagnostics Market Size (2019-2030)
6.2 North America Multiplexed Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Multiplexed Diagnostics Market Size by Country (2019-2024)
6.4 North America Multiplexed Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multiplexed Diagnostics Market Size (2019-2030)
7.2 Europe Multiplexed Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Multiplexed Diagnostics Market Size by Country (2019-2024)
7.4 Europe Multiplexed Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multiplexed Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Multiplexed Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Multiplexed Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Multiplexed Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multiplexed Diagnostics Market Size (2019-2030)
9.2 Latin America Multiplexed Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Multiplexed Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Multiplexed Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiplexed Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Multiplexed Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Multiplexed Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Multiplexed Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Multiplexed Diagnostics Introduction
11.1.4 Agilent Technologies Revenue in Multiplexed Diagnostics Business (2019-2024)
11.1.5 Agilent Technologies Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Multiplexed Diagnostics Introduction
11.2.4 Bio-Rad Laboratories Revenue in Multiplexed Diagnostics Business (2019-2024)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Detail
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Multiplexed Diagnostics Introduction
11.3.4 BioMerieux Revenue in Multiplexed Diagnostics Business (2019-2024)
11.3.5 BioMerieux Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Detail
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Multiplexed Diagnostics Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Multiplexed Diagnostics Business (2019-2024)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina Multiplexed Diagnostics Introduction
11.5.4 Illumina Revenue in Multiplexed Diagnostics Business (2019-2024)
11.5.5 Illumina Recent Development
11.6 Luminex
11.6.1 Luminex Company Detail
11.6.2 Luminex Business Overview
11.6.3 Luminex Multiplexed Diagnostics Introduction
11.6.4 Luminex Revenue in Multiplexed Diagnostics Business (2019-2024)
11.6.5 Luminex Recent Development
11.7 Hologic
11.7.1 Hologic Company Detail
11.7.2 Hologic Business Overview
11.7.3 Hologic Multiplexed Diagnostics Introduction
11.7.4 Hologic Revenue in Multiplexed Diagnostics Business (2019-2024)
11.7.5 Hologic Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Multiplexed Diagnostics Introduction
11.8.4 Thermo Fisher Scientific Revenue in Multiplexed Diagnostics Business (2019-2024)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Siemens Healthineers
11.9.1 Siemens Healthineers Company Detail
11.9.2 Siemens Healthineers Business Overview
11.9.3 Siemens Healthineers Multiplexed Diagnostics Introduction
11.9.4 Siemens Healthineers Revenue in Multiplexed Diagnostics Business (2019-2024)
11.9.5 Siemens Healthineers Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Detail
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Multiplexed Diagnostics Introduction
11.10.4 Abbott Laboratories Revenue in Multiplexed Diagnostics Business (2019-2024)
11.10.5 Abbott Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
